New combo therapy aims to shrink stomach cancer spread
Disease control
Not yet recruiting
This study tests a treatment plan for people with stomach cancer that has spread to the lining of the abdomen. The plan combines heated chemotherapy directly in the abdomen (HIPEC), standard chemotherapy, and an immunotherapy drug called tislelizumab. The goal is to see if this c…
Phase: PHASE2 • Sponsor: Hebei Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC